Therini Bio

San Francisco, United States

Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.

$39.0M raised

May 2025

Series A

Top Investors

Eli LillySV Health InvestorsApollo Health VenturesNational Institutes of HealthMRL Ventures Fund

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Therini Bio raised?

Therini Bio has raised $39.0M in total funding. The most recent round was Series A. The last funding was announced in May 2025.

Who are Therini Bio's investors?

Therini Bio's investors include Eli Lilly, SV Health Investors, Apollo Health Ventures, National Institutes of Health, MRL Ventures Fund.

Where is Therini Bio headquartered?

Therini Bio is headquartered in San Francisco, United States.

What does Therini Bio do?

Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.

What stage is Therini Bio at?

Therini Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 14, 2025.

MLA

"Therini Bio — Funding & Investors." VCBacked, May 14, 2025, https://www.vcbacked.co/company/therini-bio. Accessed June 3, 2026.

APA

VCBacked. (2025). Therini Bio — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/therini-bio

Wikipedia (cite web)

{{cite web |title=Therini Bio — Funding & Investors |url=https://www.vcbacked.co/company/therini-bio |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 14, 2025.